These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20881850)
1. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study. Meng F; Luo C; Hu Y; Yin M; Lin M; Lou G; Zhou R Int J Gynecol Pathol; 2010 Nov; 29(6):587-93. PubMed ID: 20881850 [TBL] [Abstract][Full Text] [Related]
2. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer. Meng F; Tan S; Liu T; Song H; Lou G Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer. Zhang H; Wei Q; Liu R; Qi S; Liang P; Qi C; Wang A; Sheng B; Li L; Xu Y PLoS One; 2014; 9(3):e91069. PubMed ID: 24651764 [TBL] [Abstract][Full Text] [Related]
4. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma. Meng FL; Yin MZ; Song HT; Yang H; Lou G; Zhou RL Int J Gynecol Cancer; 2010 Jul; 20(5):745-50. PubMed ID: 20966643 [TBL] [Abstract][Full Text] [Related]
5. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
6. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer. Xiao M; Jia S; Wang H; Wang J; Huang Y; Li Z J Cancer Res Clin Oncol; 2013 Apr; 139(4):661-7. PubMed ID: 23292099 [TBL] [Abstract][Full Text] [Related]
8. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886 [TBL] [Abstract][Full Text] [Related]
9. High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma. Hou T; Liang D; Yang D; He J; Huang Y; Zhang Y Int J Clin Exp Pathol; 2014; 7(3):1060-8. PubMed ID: 24695578 [TBL] [Abstract][Full Text] [Related]
10. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. Yang H; Lin M; Xiong F; Yang Y; Nie X; McNutt MA; Zhou R Surg Today; 2011 Jun; 41(6):810-7. PubMed ID: 21626328 [TBL] [Abstract][Full Text] [Related]
11. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer. Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880 [TBL] [Abstract][Full Text] [Related]
12. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer. Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643 [TBL] [Abstract][Full Text] [Related]
13. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix. Chen G; He C; Li L; Lin A; Zheng X; He E; Skog S BMC Cancer; 2013 May; 13():249. PubMed ID: 23693054 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer. Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841 [TBL] [Abstract][Full Text] [Related]
15. Elevated lysosome-associated protein transmembrane-4β-35 is an independent prognostic marker in pancreatic carcinoma. Zhang G; Liang Y; Huang Y; Chen Y; Zhou R J Int Med Res; 2012; 40(4):1275-83. PubMed ID: 22971479 [TBL] [Abstract][Full Text] [Related]
16. LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors. Yin M; Lou C; Zhang W; Meng F; Zhang H; Ning X; Zhou R; Dong X; Lou G Int J Gynecol Cancer; 2012 Jan; 22(1):54-62. PubMed ID: 22193644 [TBL] [Abstract][Full Text] [Related]
17. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis. Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495 [TBL] [Abstract][Full Text] [Related]
18. NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma. Gu L; Xia B; Zhong L; Ma Y; Liu L; Yang L; Lou G Tumour Biol; 2014 Aug; 35(8):7831-6. PubMed ID: 24819170 [TBL] [Abstract][Full Text] [Related]
19. Expression of P21-activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma. Feng Y; Fang S; Li M J Obstet Gynaecol Res; 2016 Jul; 42(7):860-9. PubMed ID: 27060895 [TBL] [Abstract][Full Text] [Related]
20. High expression of astrocyte elevated gene-1 (AEG-1) is associated with progression of cervical intraepithelial neoplasia and unfavorable prognosis in cervical cancer. Huang K; Li LA; Meng Y; You Y; Fu X; Song L World J Surg Oncol; 2013 Nov; 11():297. PubMed ID: 24256614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]